NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Perennial allergic rhinitis
Date of first enrollment	13/09/2005
Target sample size	30
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : Cetirizine INN of investigational material : Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Safety,change in the total nasal symptom score, etc.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 2age old
Age maximum	<= 14age old
Gender
Include criteria	Age: 2 to 14, Children with perennial allergic rhinitis, patients eligible for evaluation of nasal symptom, etc.
Exclude criteria